TNF and psoriasis: Two patients (out of the eighteen with documented outcomes) experienced serious adverse events upon restarting anti-TNF therapy: one had an anaphylactic infusion reaction and another developed severe psoriasis, necessitating discontinuation of the anti-TNF.